Lihua Chen
Taizhou, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 14 publications
Impact of oral bacterial lysates on asthma control and immune parameters in children: evidence from an updated systematic review and meta-analysis of randomized trials.
Journal: Frontiers in pharmacology
Published: February 01, 2026
Corrigendum to "Inhibition of heat shock protein 90 rescues glucocorticoid-induced bone loss through enhancing bone formation" J. Steroid Biochem. Mol. Biol. 171 (July) (2017) 236-246.
Journal: The Journal of steroid biochemistry and molecular biology
Published: November 10, 2023
Upregulation of cIAP1 induced by AZD8330 alleviates osteoarthritis progression by inhibiting the RIP1-associated necrosis signaling pathway.
Journal: International immunopharmacology
Published: August 13, 2023
AS-605240 Blunts Osteoporosis by Inhibition of Bone Resorption.
Journal: Drug design, development and therapy
Published: December 31, 2022
AZ-628 delays osteoarthritis progression via inhibiting the TNF-α-induced chondrocyte necroptosis and regulating osteoclast formation.
Journal: International immunopharmacology
Published: May 08, 2022
Selumetinib - a potential small molecule inhibitor for osteoarthritis treatment.
Journal: Frontiers in pharmacology
Published: May 07, 2022
Platelet-Derived Growth Factor-BB Inhibits Intervertebral Disc Degeneration via Suppressing Pyroptosis and Activating the MAPK Signaling Pathway.
Journal: Frontiers in pharmacology
Published: October 21, 2021
Inhibition of Lipopolysaccharide-Induced Inflammatory Bone Loss by Saikosaponin D is Associated with Regulation of the RANKL/RANK Pathway.
Journal: Drug design, development and therapy
Published: August 20, 2021
Neferine suppresses osteoclast differentiation through suppressing NF-κB signal pathway but not MAPKs and promote osteogenesis.
Journal: Journal of cellular physiology
Published: December 12, 2018
Histone deacetylase inhibitor CI-994 inhibits osteoclastogenesis via suppressing NF-κB and the downstream c-Fos/NFATc1 signaling pathways.
Journal: European journal of pharmacology
Published: September 30, 2018
Last Updated: 09/26/2026